However, there exists a higher rate of relapse in these individuals, and the transplanted immune cells may harm regular tissues also, causing graft-versus-sponsor disease . Now, researchers at Dana-Farber Cancers Institute statement in the Journal of Clinical Investigation that they noticed a solid and selective immune response in a few patients who received, after the transplant shortly, several dosages of a customized tumor vaccine made up of their very own inactivated leukemia cells coupled with an immune stimulant, GM-CSF. Therefore the vaccine boosted the energy of the transplanted immune program's capability to attack the malignancy – referred to as the graft-versus-leukemia effect. Our research claim that autologous tumor cell vaccination is an efficient strategy to progress long-term leukemia control pursuing transplants from donors, stated Catherine Wu, MD, senior author.We’ve had products available for 50 years: PCBs, asbestos, tobacco, DDT. In early stages people said these were secure,’ answered Krimsky. Weintraub covered up the interview by requesting if anything would convince Krimsky that GMOs are secure. ‘I would experience convinced if there have been independent research asking the right queries and seeking experiments searching for the most vulnerable situations,’ he replied. A reprint of the interview by GMWatch corrected some of Weintraub’s factors, including that there is nothing at all ‘unrealistic’ about Seralini’s long-term safety research on GM maize NK603 and Roundup. Second of all, relating to Weintraub’s comment about one unfavorable study carrying more excess weight than a large number of positive types, GMWatch points out there are no other long-term security research on GM corn.